1. Home
  2. TEVA vs SNA Comparison

TEVA vs SNA Comparison

Compare TEVA & SNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • SNA
  • Stock Information
  • Founded
  • TEVA 1901
  • SNA 1920
  • Country
  • TEVA Israel
  • SNA United States
  • Employees
  • TEVA N/A
  • SNA N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • SNA Industrial Machinery/Components
  • Sector
  • TEVA Health Care
  • SNA Consumer Discretionary
  • Exchange
  • TEVA Nasdaq
  • SNA Nasdaq
  • Market Cap
  • TEVA 21.2B
  • SNA 18.1B
  • IPO Year
  • TEVA N/A
  • SNA N/A
  • Fundamental
  • Price
  • TEVA $20.02
  • SNA $336.32
  • Analyst Decision
  • TEVA Strong Buy
  • SNA Buy
  • Analyst Count
  • TEVA 7
  • SNA 6
  • Target Price
  • TEVA $25.57
  • SNA $357.00
  • AVG Volume (30 Days)
  • TEVA 10.3M
  • SNA 343.7K
  • Earning Date
  • TEVA 11-05-2025
  • SNA 10-16-2025
  • Dividend Yield
  • TEVA N/A
  • SNA 2.54%
  • EPS Growth
  • TEVA N/A
  • SNA N/A
  • EPS
  • TEVA N/A
  • SNA 18.77
  • Revenue
  • TEVA $16,628,000,000.00
  • SNA $5,070,900,000.00
  • Revenue This Year
  • TEVA $4.07
  • SNA N/A
  • Revenue Next Year
  • TEVA $0.81
  • SNA $3.75
  • P/E Ratio
  • TEVA N/A
  • SNA $17.95
  • Revenue Growth
  • TEVA 2.08
  • SNA N/A
  • 52 Week Low
  • TEVA $12.47
  • SNA $284.38
  • 52 Week High
  • TEVA $22.80
  • SNA $373.90
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 61.37
  • SNA 48.40
  • Support Level
  • TEVA $19.87
  • SNA $342.69
  • Resistance Level
  • TEVA $20.61
  • SNA $350.30
  • Average True Range (ATR)
  • TEVA 0.61
  • SNA 5.62
  • MACD
  • TEVA 0.05
  • SNA -0.46
  • Stochastic Oscillator
  • TEVA 75.12
  • SNA 22.90

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About SNA Snap-On Incorporated

Snap-on is a manufacturer of premium tools, equipment, and diagnostics for professional technicians, primarily involved in the repair of passenger cars, but has expanded into other industrial applications. The company's legacy business is selling hand tools through franchisee-operated mobile vans to technicians who purchase the tools at their own expense. The company also operates a commercial and industrial business, focusing on repair facilities that serve other industries. The third segment, repair systems and information, targets auto OEMs and large dealerships more directly, also offering substantial diagnostic solutions to aid in repairs. The company's finance arm provides financing to franchisees to support their operations, as well as underwrites end-customer purchases.

Share on Social Networks: